OncoMed Pharmaceuticals Inc

CIK 1302573 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for OncoMed Pharmaceuticals Inc.

Recent SEC filings

FiledFormAccession number
May 3, 201915-12B0000950103-19-005954
Apr 26, 2019SC 13D/A0000921895-19-001178
Apr 24, 2019S-8 POS0000950103-19-005052
Apr 24, 2019S-8 POS0000950103-19-005051
Apr 24, 2019S-8 POS0000950103-19-005054
Apr 24, 2019S-8 POS0000950103-19-005055
Apr 24, 2019S-8 POS0000950103-19-005053
Apr 24, 2019S-8 POS0000950103-19-005050
Apr 23, 201940000899243-19-010985
Apr 23, 201940000899243-19-010989
Apr 23, 201940000899243-19-010987
Apr 23, 201940000899243-19-010984
Apr 23, 20198-K0001193125-19-114997
Apr 23, 201940000899243-19-010988
Apr 23, 201940000899243-19-010983
Apr 23, 201940000899243-19-010990
Apr 23, 201925-NSE0001354457-19-000214
Apr 23, 201940000899243-19-010986
Apr 17, 20194250001193125-19-109015
Apr 17, 20198-K0001193125-19-109014
Mar 20, 2019DEFM14A0001193125-19-080933
Mar 15, 2019SC 13D0000921895-19-000758
Mar 15, 20194250001193125-19-075601
Mar 15, 20194250000950103-19-003428
Mar 15, 20198-K0001193125-19-075599